Shu Lee-Lean 4

What Happened

• Shu Lee‑Lean (President, CEO, Chairman and Director) exercised options and sold the resulting shares in two batches. On 2026-03-16 she exercised 30,734 options at $4.99 ($153,363) and sold 30,734 shares for about $308,035. On 2026-03-17 she exercised 36,517 options at $4.99 ($182,220) and sold 36,517 shares for about $365,594. Total shares exercised: 67,251; total exercise cost: $335,583; total sale proceeds: $673,629.

Key Details

• Transaction dates: March 16, 2026 and March 17, 2026. Form filed March 17, 2026 (timely).
• Exercise price: $4.99 per share. Sale weighted-average prices: ~$10.02 (3/16) and ~$10.01 (3/17); reported sales occurred at prices in ranges $10.00–$10.10 and $10.00–$10.065 (see footnotes).
• Shares owned after the transactions: not specified in the Form 4 filing.
• Notable footnotes: F1 — sales were executed under a Rule 10b5‑1 trading plan adopted Nov 4, 2025. F2/F3 — reported sale prices are weighted averages; the filer can provide a breakdown of shares sold at each price on request.
• Derivative entries showing $0 are bookkeeping entries associated with disposition/termination of the exercised derivative instruments.

Context

• This was an exercise of derivatives (stock options) followed by immediate open‑market sales of the resulting shares (effectively a cashless exercise/sale). Such exercises and subsequent sales are common for executives monetizing vested options and, by themselves, do not necessarily indicate a change in the insider’s view of the company.